Reunion Neuroscience Schedules Fiscal Second Quarter 2023 Conference Call for Monday, November 14, 2022, at 8:30 A.M. ET
TORONTO, Nov. 07, 2022 (GLOBE NEWSWIRE) — Reunion Neuroscience Inc. (NASDAQ:REUN, TSX:REUN) (“Reunion” or the “Company”), a biopharmaceutical company committed to developing innovative therapeutic solutions for underserved mental health conditions, announced today that it plans to release its business update and financial results for its fiscal 2023 second quarter ended September 30, 2022, before market open on Monday, November 14, 2022.
Related news for (REUN)
- Reunion Neuroscience to Participate in the Oppenheimer Annual Healthcare Conference
- Reunion Neuroscience Provides Business Update and Reports Fiscal Third Quarter 2023 Financial Results
- Reunion Neuroscience Inc. Completes Interim Data Analysis for Phase 1 Clinical Trial with Novel Serotonergic Psychedelic RE104
- KCSA Mental Health Virtual Investor Conference: Presentations Now Available for Online Viewing
- KCSA Mental Health Virtual Investor Conference Agenda Announced for December 15th